Navigation Links
Reduced Fatigue Boosts Mental Health

An improvement in fatigue may reduce anxiety and depression in cancer patients. For patients with anemia, investigators say fatigue may be improved or reversed with the drug Aranesp.
Participants in the international study were anemic patients undergoing chemotherapy to treat lung cancer. They either received Aranesp at a starting dose of 2.25 micrograms or a placebo once a week for 12 weeks. Patients then completed questionnaires.//

At the beginning of the study, 25 percent of patients reported high levels of anxiety while 35 percent of patients reported high levels of depression, both higher levels than are reported by the general population of lung cancer patients. Researchers found for every unit of improvement in fatigue scores on the questionnaires, there was an improvement of 0.7 points in anxiety and 0.8 points in depression.

According to previous studies, the most frequently identified symptom of psychological distress that accompanies lung cancer is fatigue. A variety of factors may contribute to the fatigue experienced by anemic patients with lung cancer, including respiratory insufficiency, hypoxemia, side effects of chemotherapy and undernutrition.
'"/>




Page: 1

Related medicine news :

1. Reduced POD linked to fatal asthma attacks
2. Reduced fertility in men who mountain bike
3. Rejection Rate for Liver Transplants Patient Reduced
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Heart Disease In Women Can Be Reduced By Eating Grapes
6. Cholesterol; Can Be Reduced By Sunflower Seeds, and Pistachios
7. Snoring To Be Reduced By New Device Called True Sleep
8. Infectious Diseases Reduced in China
9. Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy
10. Breast Cancer Treatment Reduced From Six Weeks To Five Days.
11. Chances Of Getting Cancer Can Be Reduced By Hysterectomy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Reduced Fatigue Boosts Mental Health

(Date:11/25/2009)...ov.25/PRNewswire/-- MISSIONSkincare ®isproudt...Jude.AspartofGNC,sannualSt.Jude ThanksandGiving ca...re,s new SUPER-C(TM)LipBalm willbedonatedtoSt.Ju...kea$1,$5or$10donationatcheckoutatoneoftheir5,000+r...1millionforSt.Judeduringtheir2009 ThanksandGiving ...
(Date:11/25/2009)...mprovementShownforthe4thStraightYear ,, WASHI...ancerAlliance-Georgia(LCA-GA)issuedthe 4thAnnualRe...ogressbeingmadeagainstthislethaldiseaseinthestateo...,theonlynationalorganizationdedicatedexclusivelyto...skforlungcancer. ,, (Logo: http://www.newscom.c...
(Date:11/25/2009)...treat colorectal cancer also can reverse a rare st... therapy for the disease, researchers at Vanderbil...ntrier,s disease causes thickening of the stomach ..., as well as anemia and swelling in the feet and a...ed risk for gastric cancer. Previously, the only e...
(Date:11/25/2009)...aced under the skin kill tumor cells, study finds ...-- A cancer vaccine delivered in a fingernail-size... study reports. , The method uses polymer disks...h tumor-specific antigens and implanted under the ...rs. The Harvard University scientists who develope...
(Date:11/25/2009)... Nationwide Imaging Services, known as one...r diagnostic imaging equipment, now offering a tot...nancing options, service and installation with acq...l Technologies of California) , ...onwide Imaging Services is proud to announce its a...
Breaking Medicine News(10 mins):Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3
...inn., Nov. 20 Forward Expeditions LLC, Ely, Minn.... historic Victorinox North,Pole expedition to rais...sota-based nonprofit organization offering free pe...0 million families each,year through personal, pri...
...TON, Pa., Nov. 20 Environmental Tectonics Corpora...Medical Systems Division has contracted with the L...ement group located in Mt. Vernon, NY, for deliver...Good Samaritan Hospital - Suffern New York. LST ut...
..., Calif., Nov. 20 STAAR Surgical Company,(Nasdaq:...f leading ophthalmic,surgeons, CAST (Collamer(R) A... in a collaborative effort in evaluating the accom...ity to "accommodate," or,to adjust to see near and...
... BY SAN DIEGO HOSPICE AND THE INSTITUTE FOR PALLIA... WHAT: , San Diego Hospice and The Institute... for coping with grief and loss during the upcomin...e of yourself first and foremost. , , 2. Fin...
...D, Conn., Nov. 20 Families looking for an easy,fu...d-winning gift option this,holiday season. Kideos...ool for,teaching kids to dance and get fit. This D...rition and exercise, Kideosyncrasy,promotes health...
... I/ITSEC, The largest exhibition...cutting-edge medical simulations ranging from mass... prediction and management on December 1-4 at the ...on of simulation technology ever held, will featur...
Other Medicine News:Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 2Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 3Health News:Forward Expeditions to Promote CaringBridge(R) on Historic Victorinox North Pole '09 Expedition 4Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 2Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 3Health News:Environmental Tectonics Corporation's BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers 4Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 2Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 3Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 4Health News:STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses 5Health News:Ten Tips for Coping with Grief and Loss During the Holidays 2Health News:Ten Tips for Coping with Grief and Loss During the Holidays 3Health News:Give Kids the Gift of Fun and Fitness This Holiday Season 2Health News:Medical Technology to be Highlighted at World's Largest Simulation Exhibition 2
(Date:11/25/2009)...wswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),...overing,developingandcommercializingnoveldrugstotr...iscalyearendedSeptember30,2009.AtSeptember30,2009P...shortterminvestments. ,, PipelineUpdateand2009...,, InlateNovember2009,anindependentDataMonitori...
(Date:11/25/2009)...e/--BioTrendsResearchGroup,Inc.releasedWave1ofits ...ulti-phasesyndicatedmarketresearchprojecttrackingt...ctlaunchthroughthefirstsixmonthsofavailability.Eac...m75uniqueDermatologistsandqualitativeinformationfr...,obstaclestouse,typicalpatienttypes,productpercept...
(Date:11/25/2009)...ewswire-USNewswire/--RemediumTechnologiesInc.,acom...ebleeding,wonfirstprizeand$10,000intheMostPromisin...009,companyofficialsannouncetoday. ,, Selectedf...teampitchedtheirinventionattheGSCSecuritySummitcon...dium( www.remediumtechnologies.com )isdevelopingah...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Group B Strep Screening Guidelines Sparing Newborns 49294 1Group B Strep Screening Guidelines Sparing Newborns 49294 2Group B Strep Screening Guidelines Sparing Newborns 49294 3Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 1Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 2Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 12680 1
...he Food and Drug,Administration (FDA) Cardiovascul...Drug Safety and Risk Management Advisory Committee...to erythropoiesis-stimulating,agents (ESA,s), Orth... key,issues that will be discussed: * The studies...luated hemoglobin targets above 13 grams per de...
...lerability with No Clinically Significant ...erence Call Scheduled for 8:30AM (ET) Today-, PRI... VRUS ) is presenting safety, tolerability, pharma...cending doses of R7128 at the 14th,International S...being held,from September 9-13, 2007 in Glasgow, S...
Other Medicine Technology:Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 2Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 3Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 4Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 5Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 3Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 4Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 5
Diamond Burr - Round
Pterygium Diamond Burr
Ruedemann Lacrimal Dilator
Wilder Lacrimal Dilator - Long
Medicine Products: